Clinical utility of plasma cell-free DNA in gliomas

Noninvasive molecular profiling of tumors using plasma-based next-generation sequencing (NGS) is increasingly used to aid in diagnosis, treatment selection, and disease monitoring in oncology. In patients with glioma, however, the plasma cell-free DNA (cfDNA) tumor fraction, defined as the fractiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenter, Erica L, Bagley, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650462/
https://www.ncbi.nlm.nih.gov/pubmed/36380864
http://dx.doi.org/10.1093/noajnl/vdac014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650462/
https://www.ncbi.nlm.nih.gov/pubmed/36380864
http://dx.doi.org/10.1093/noajnl/vdac014

Ejemplares similares